Empliciti IV infusion 300mg, manufactured by Bristol-Myers Squibb, contains Elotuzumab (genetical recombination), a humanized IgG1 monoclonal antibody. It is used in combination with other medicines for the treatment of multiple myeloma. This 300mg bottle has a YJ code of 4291434D1020.
Empliciti IV infusion 300mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →